EPSC 2027 will bring together leading peptide chemists, process scientists, pharmaceutical innovators, CROs, technology providers, and academic researchers for an in-depth exploration of advances in peptide science and manufacturing. The conference will provide a focused platform to examine the full peptide lifecycle—from early discovery and screening through scale-up, purification, analysis, and regulatory readiness.

The scientific programme will cover:

• Emerging strategies in solid-phase and solution-phase peptide synthesis
• High-throughput library generation and screening technologies
• Process optimisation, automation, and digital integration
• Scale-up from research to GMP manufacturing
• Sustainability and green chemistry in peptide production
• Analytical characterisation, impurity profiling, and quality control
• Regulatory considerations and CMC strategies for peptide therapeutics
• Case studies from pharma, biotech, and CDMO environments

In addition to technical presentations, EPSC 2027 will facilitate interactive panel discussions, application workshops, and dedicated exhibition sessions designed to encourage collaboration between instrument developers, raw material suppliers, and end users.

The aims of EPSC 2027 are to:

1. Showcase innovation across peptide discovery, development, and manufacturing.
2. Bridge the gap between academic research and industrial implementation.
3. Provide practical, application-driven insights that attendees can implement immediately.
4. Support scalable, sustainable, and regulatory-ready peptide production.
5. Strengthen the global peptide science community through meaningful networking and collaboration.

EPSC 2027 is designed to be both scientifically rigorous and commercially relevant—equipping delegates with the knowledge, tools, and connections needed to advance peptide research and manufacturing in an increasingly complex therapeutic landscape.